Annual report pursuant to Section 13 and 15(d)

Significant Customers

Significant Customers
12 Months Ended
Dec. 31, 2015
Risks and Uncertainties [Abstract]  
Significant Customers



Our products are distributed through national chain, regional, specialty and local retail stores throughout the United States. Revenues for Fiscal 2015, 2014 and 2013 were $20.6 million, $22.1 million and $25.0 million, respectively. Walgreen Company (“Walgreens”) and Wal-Mart Stores Inc (“Wal-Mart”) accounted for approximately 15.8% and 11.3% respectively, for Fiscal 2015. Walgreens, Wal-Mart and CVS Health Corporation (“CVS”) accounted for approximately 18.9%, 16.9% and 11.3%, respectively, of our Fiscal 2014 revenues. Walgreens, Wal-Mart and CVS accounted for approximately 20.4%, 14.3% and 11.6%, respectively, of our Fiscal 2013 revenues. The loss of sales to any one or more of these large retail customers could have a material adverse effect on our business operations and financial condition.


We are subject to account receivable credit concentrations from time-to-time as a consequence of the timing, payment pattern and ultimate purchase volumes or shipping schedules with our customers. These concentrations may impact our overall exposure to credit risk, either positively or negatively, in that our customers may be similarly affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of amounts due to us. Customers comprising the five largest accounts receivable balances represented 60% and 67% of total trade receivable balances at December 31, 2015 and 2014, respectively. Management believes that the provision for possible losses on uncollectible accounts receivable is adequate for our credit loss exposure. The allowance for doubtful accounts was zero for both December 31, 2015 and 2014.